Skip to main content
bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · IEX Real-Time Price · USD
2.450
-0.050 (-2.00%)
At close: Jul 19, 2024, 4:00 PM
2.650
+0.200 (8.16%)
Pre-market: Jul 22, 2024, 7:19 AM EDT

bioAffinity Technologies Revenue

bioAffinity Technologies had revenue of $4.94M in the twelve months ending March 31, 2024, with 86,182.88% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.41M with 261,180.24% year-over-year growth. In the year 2023, bioAffinity Technologies had annual revenue of $2.53M with 52,627.44% growth.

Revenue (ttm)
$4.94M
Revenue Growth
+86,182.88%
P/S Ratio
5.78
Revenue / Employee
$352,712
Employees
14
Market Cap
28.56M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.53M2.53M52,627.44%
Dec 31, 20224.80K--
Dec 31, 20210--
Dec 31, 20200--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

BIAF News

More News